Prachem Laboratories Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 17-11-2024
- Paid Up Capital ₹ 3.00 Cr
as on 17-11-2024
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 20.48 Cr
as on 17-11-2024
- Revenue 5.49%
(FY 2023)
- Profit 8.46%
(FY 2023)
- Ebitda 33.16%
(FY 2023)
- Net Worth 60.76%
(FY 2023)
- Total Assets 21.26%
(FY 2023)
About Prachem Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 3.00 Cr.
The company currently has active open charges totaling ₹20.48 Cr.
Pravinkumar Patel and Girishbhai Patel serve as directors at the Company.
- CIN/LLPIN
U24100GJ2020PTC117543
- Company No.
117543
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Oct 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Gandhi Nagar, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Prachem Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pravinkumar Patel  | Director | 21-Oct-2020 | Current |
| Girishbhai Patel | Director | 21-Oct-2020 | Current |
Financial Performance of Prachem Laboratories.
Prachem Laboratories Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.49% increase. The company also saw a slight improvement in profitability, with a 8.46% increase in profit. The company's net worth Soared by an impressive increase of 60.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prachem Laboratories?
In 2023, Prachem Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
₹20.48 Cr
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 10.48 Cr
- The Hongkong And Shanghai Banking Corporation Limited : 10.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Mar 2023 | The Hongkong And Shanghai Banking Corporation Limited | ₹10.00 Cr | Open |
| 04 Jan 2021 | Hdfc Bank Limited | ₹10.48 Cr | Open |
How Many Employees Work at Prachem Laboratories?
Prachem Laboratories has a workforce of 50 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prachem Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prachem Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.